Absolute benefit measures are essential for guiding therapies in COPD in an era of precision medicine: a viewpoint on "number needed to treat"

Publication: European Respiratory Journal
UBC Author(s): Mohsen Sadatsafavi (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 66
Publication Date: 1 November 2025